Table 1.
Demographic and clinical characteristics of 4606 COVID-19 tested cancer subjects in the UK Biobank
| COVID-19 positive associated | COVID-19 negative associated | |||||
| Fatalities | (%) | Survivors | Fatalities | (%) | Survivors | |
| Race | ||||||
| British ancestry | 64 | (22.2) | 224 | 153 | (3.5) | 4165 |
| Age (years) | ||||||
| 50–59 | 2 | (7.1) | 26 | 8 | (2.9) | 271 |
| 60–69 | 6 | (9.7) | 56 | 26 | (3.0) | 850 |
| 70–79 | 42 | (26.4) | 117 | 94 | (3.5) | 2562 |
| 80–84 | 14 | (35.9) | 25 | 25 | (4.9) | 482 |
| Sex | ||||||
| Male | 40 | (23.8) | 128 | 90 | (3.8) | 2285 |
| Female | 24 | (20.0) | 96 | 63 | (3.2) | 1880 |
| History of cancer (years) | ||||||
| >10 | 18 | (27.7) | 47 | 35 | (3.4) | 1008 |
| 5<years ≤10 | 15 | (18.5) | 66 | 24 | (2.3) | 1005 |
| 1<years ≤5 | 3 | (13.0) | 20 | 8 | (4.3) | 178 |
| ≤1 | 28 | (23.5) | 91 | 86 | (4.2) | 1974 |